Yingzi Wang
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
Papers in
-
- Bioactive Natural Diterpenoids Research 9
- Ginseng Biological Effects and Applications 5
- Natural product bioactivities and synthesis 4
- Co-authors
- David Twomey (1 shared paper)Jason Levine (1 shared paper)Joerg Faber (1 shared paper)William C. Hahn (1 shared paper)Todd R. Golub (1 shared paper)Andrei V. Krivtsov (2 shared papers)Jing Wang (1 shared paper)Zhaohui Feng (1 shared paper)
- Journals
- Journal of Nanoscience and Nanotechnology (3 papers)Biomedical Chromatography (3 papers)Food & Function (2 papers)Phytomedicine (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- ChinaUnited StatesEgypt
In The Last Decade
Yingzi Wang
84 papers receiving 2.3k citations
Yingzi Wang's Hit Papers
Peers
Comparison fields: 5 of 126
- Hematology 507
- Molecular Biology 1.1k
- Cancer Research 206
- Oncology 349
- Biological Psychiatry 28
Countries citing papers authored by Yingzi Wang
This map shows the geographic impact of Yingzi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingzi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingzi Wang more than expected).
Fields of papers citing papers by Yingzi Wang
This network shows the impact of papers produced by Yingzi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingzi Wang. The network helps show where Yingzi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yingzi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 Hit paper breakdown → | 2006 | 1052 |
| 2 | 2004 | 105 | |
| 3 | 2013 | 86 | |
| 4 | 2015 | 70 | |
| 5 | 2011 | 65 | |
| 6 | 2006 | 58 | |
| 7 | 2008 | 56 | |
| 8 | 2012 | 47 | |
| 9 | 2020 | 47 | |
| 10 | 2012 | 38 | |
| 11 | 2022 | 37 | |
| 12 | 2021 | 35 | |
| 13 | 2015 | 33 | |
| 14 | 2018 | 31 | |
| 15 | 2008 | 29 | |
| 16 | 2021 | 29 | |
| 17 | 2009 | 29 | |
| 18 | 2018 | 28 | |
| 19 | 2013 | 27 | |
| 20 | 2018 | 27 |
About Yingzi Wang
Yingzi Wang is a scholar working on Molecular Biology, Plant Science, Pharmacology, Pharmacology and Complementary and alternative medicine, having authored 93 papers that have together received 2.4k indexed citations. Recurring topics across this work include Bioactive Natural Diterpenoids Research (9 papers), Traditional Chinese Medicine Analysis (7 papers), Tea Polyphenols and Effects (7 papers), Ginseng Biological Effects and Applications (5 papers), Plant-based Medicinal Research (5 papers), Natural product bioactivities and synthesis (4 papers), Pharmacological Effects of Natural Compounds (4 papers) and Fungal Biology and Applications (4 papers). The work is most often cited by research in Hematology (507 citations), Molecular Biology (1.1k citations), Cancer Research (206 citations), Oncology (349 citations) and Biological Psychiatry (28 citations). Yingzi Wang has collaborated with scholars based in China, United States and Egypt. Frequent co-authors include David Twomey, Jason Levine, Joerg Faber, William C. Hahn, Todd R. Golub, Andrei V. Krivtsov, Jing Wang, Zhaohui Feng, D. Gary Gilliland and Matthew C. Stubbs. Their work appears in journals such as Journal of Nanoscience and Nanotechnology, Biomedical Chromatography, Food & Function, Phytomedicine and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.